X-73213937-A-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_021963.4(NAP1L2):c.556T>A(p.Tyr186Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,208,692 control chromosomes in the GnomAD database, including 1 homozygotes. There are 90 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y186C) has been classified as Uncertain significance.
Frequency
Consequence
NM_021963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000154 AC: 17AN: 110636Hom.: 0 Cov.: 22 AF XY: 0.000152 AC XY: 5AN XY: 32846
GnomAD3 exomes AF: 0.000224 AC: 41AN: 183253Hom.: 1 AF XY: 0.000236 AC XY: 16AN XY: 67753
GnomAD4 exome AF: 0.000229 AC: 251AN: 1098056Hom.: 1 Cov.: 32 AF XY: 0.000234 AC XY: 85AN XY: 363414
GnomAD4 genome AF: 0.000154 AC: 17AN: 110636Hom.: 0 Cov.: 22 AF XY: 0.000152 AC XY: 5AN XY: 32846
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.556T>A (p.Y186N) alteration is located in exon 1 (coding exon 1) of the NAP1L2 gene. This alteration results from a T to A substitution at nucleotide position 556, causing the tyrosine (Y) at amino acid position 186 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at